Ryogo Kikuchi

Dr. Ryogo Kikuchi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RKRyogo Kikuchi
Ryogo Kikuchi
RURyo Ueda
Ryo Ueda
KSKatsuya Saito
Katsuya Saito
SSShunsuke Shibao
Shunsuke Shibao
HNHideaki Nagashima
Hideaki Nagashima
MTMasahiro Toda
Masahiro Toda
High-grade gliomas (HGGs) carry a dismal prognosis despite current treatments. We previously confirmed the safety and immunogenicity of a vaccine treatment targeting tumor angiogenesis with synthetic peptides, for vascular endothelial growth factor receptor (VEGFR) epitopes in recurrent HGG patients. In this study, we evaluated a novel vaccine therapy targeting not only tumor vasculature but also tumor cells, using multiple glioma oncoantigen (GOA)/glioma angiogenesis-associated antigen (GAAA) peptides in HLA-A2402+ recurrent/progressive HGG patients. The vaccine included peptide epitopes from four GOAs (LY6K, DEPDC1, KIF20A, and FOXM1) and two GAAAs (VEGFR1 and VEGFR2). Ten patients received subcutaneous vaccinations. The primary endpoint was the safety of the treatment. T-lymphocyte responses against GOA/GAAA epitopes and treatment response were evaluated secondarily. The treatment was well tolerated without any severe systemic adverse events. The vaccinations induced immunoreactivity to at least three vaccine-targeted GOA/GAAA in all six evaluable patients. The median overall survival time in all patients was 9.2 months. Five achieved progression-free status lasting at least six months. Two recurrent glioblastoma patients demonstrated stable disease. One patient with anaplastic oligoastrocytoma achieved complete response nine months after the vaccination. Taken together, this regimen was well tolerated and induced robust GOA/GAAA-specific T-lymphocyte responses in recurrent/progressive HGG patients.

1 September 2016 in World Neurosurgery
Verified
Journal Article
Closed access
RKRyogo Kikuchi
Ryogo Kikuchi
MTMasahiro Toda
Masahiro Toda
SWSota Wakahara
Sota Wakahara
HFHirokazu Fujiwara
Hirokazu Fujiwara
MJMasahiro Jinzaki
Masahiro Jinzaki
KYKazunari Yoshida
Kazunari Yoshida

1 January 2015 in Surgical Neurology International
Verified
Journal Article
Open access
RKRyogo Kikuchi
Ryogo Kikuchi
MTMasahiro Toda
Masahiro Toda
TTToshiki Tomita
Toshiki Tomita
KOKaoru Ogawa
Kaoru Ogawa
KYKazunari Yoshida
Kazunari Yoshida
Wide variations were observed in SSLP and SSW. For EEA, pneumatization is an instrument corridor. Preoperative assessment of SSLP is important, especially for parasellar lesions.

1 December 2019 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
HYHiroki Yamada
Hiroki Yamada
RKRyogo Kikuchi
Ryogo Kikuchi
ANAkiyoshi Nakamura
Akiyoshi Nakamura
HMHiromichi Miyazaki
Hiromichi Miyazaki